328 related articles for article (PubMed ID: 30128744)
1. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
3. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
[TBL] [Abstract][Full Text] [Related]
4. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
[TBL] [Abstract][Full Text] [Related]
5. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
6. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
[TBL] [Abstract][Full Text] [Related]
7. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease.
Nichols B; Briola A; Logan M; Havlik J; Mascellani A; Gkikas K; Milling S; Ijaz UZ; Quince C; Svolos V; Russell RK; Hansen R; Gerasimidis K
Am J Clin Nutr; 2024 Apr; 119(4):885-895. PubMed ID: 38569785
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP.
Moriczi M; Pujol-Muncunill G; Martín-Masot R; Jiménez Treviño S; Segarra Cantón O; Ochoa Sangrador C; Peña Quintana L; González Santana D; Rodríguez Martínez A; Rosell Camps A; Armas H; Barrio J; González de Caldas R; Rodríguez Salas M; Balmaseda Serrano E; Donat Aliaga E; Bodas Pinedo A; Vaquero Sosa E; Vecino López R; Solar Boga A; Moreno Álvarez A; Sánchez Sánchez C; Tolín Hernani M; Gutiérrez Junquera C; Martinón Torres N; Leis Trabazo MR; Eizaguirre FJ; García Peris M; Medina Benítez E; Fernández Caamaño B; Vegas Álvarez AM; Crespo Valderrábano L; Alonso Vicente C; Rubio Santiago J; Galera-Martínez R; García-Romero R; Ros Arnal I; Fernández Cebrián S; Lorenzo Garrido H; Viada Bris JF; Velasco Rodríguez-Belvis M; Bartolomé Porro JM; Blanco Rodríguez M; Barros García P; Botija G; Chicano Marín FJ; La Orden Izquierdo E; Crehuá-Gaudiza E; Navas-López VM; Martín-de-Carpi J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32272604
[TBL] [Abstract][Full Text] [Related]
9. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
10. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease.
Tjellström B; Högberg L; Stenhammar L; Magnusson KE; Midtvedt T; Norin E; Sundqvist T
Scand J Gastroenterol; 2012 Dec; 47(12):1454-9. PubMed ID: 23016828
[TBL] [Abstract][Full Text] [Related]
11. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
12. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
[TBL] [Abstract][Full Text] [Related]
14. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S
Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487
[TBL] [Abstract][Full Text] [Related]
15. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition.
Nahidi L; Leach ST; Sidler MA; Levin A; Lemberg DA; Day AS
Inflamm Bowel Dis; 2011 Feb; 17(2):516-23. PubMed ID: 20848544
[TBL] [Abstract][Full Text] [Related]
17. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
Frivolt K; Schwerd T; Werkstetter KJ; Schwarzer A; Schatz SB; Bufler P; Koletzko S
Aliment Pharmacol Ther; 2014 Jun; 39(12):1398-407. PubMed ID: 24779671
[TBL] [Abstract][Full Text] [Related]
18. Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.
Quince C; Ijaz UZ; Loman N; Eren AM; Saulnier D; Russell J; Haig SJ; Calus ST; Quick J; Barclay A; Bertz M; Blaut M; Hansen R; McGrogan P; Russell RK; Edwards CA; Gerasimidis K
Am J Gastroenterol; 2015 Dec; 110(12):1718-29; quiz 1730. PubMed ID: 26526081
[TBL] [Abstract][Full Text] [Related]
19. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands.
de Bie C; Kindermann A; Escher J
J Crohns Colitis; 2013 May; 7(4):263-70. PubMed ID: 22820027
[TBL] [Abstract][Full Text] [Related]
20. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
Urlep D; Benedik E; Brecelj J; Orel R
Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
